Anna Suk‐Fong Lok

2.4k total citations
21 papers, 1.4k citations indexed

About

Anna Suk‐Fong Lok is a scholar working on Epidemiology, Hepatology and Gastroenterology. According to data from OpenAlex, Anna Suk‐Fong Lok has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Hepatology and 2 papers in Gastroenterology. Recurrent topics in Anna Suk‐Fong Lok's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (9 papers). Anna Suk‐Fong Lok is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (9 papers). Anna Suk‐Fong Lok collaborates with scholars based in United States, Hong Kong and China. Anna Suk‐Fong Lok's co-authors include Ching‐Lung Lai, Hari S. Conjeevaram, Hsiang‐Ju Lin, Pui–Chee Wu, Eng‐Kiong Yeoh, H J Lin, Fabien Zoulim, Norah A. Terrault, Markus Cornberg and Chi‐Jen Chu and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Anna Suk‐Fong Lok

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Suk‐Fong Lok United States 17 1.1k 1.1k 148 127 119 21 1.4k
Hideharu Harada Japan 13 1.3k 1.1× 984 0.9× 157 1.1× 163 1.3× 260 2.2× 26 1.6k
Jane Fang United States 19 755 0.7× 740 0.7× 114 0.8× 207 1.6× 282 2.4× 35 1.3k
Akito Nozaki Japan 18 697 0.6× 559 0.5× 124 0.8× 84 0.7× 201 1.7× 47 1.3k
Byung‐Cheol Song South Korea 19 965 0.8× 792 0.7× 83 0.6× 127 1.0× 179 1.5× 60 1.3k
J L Sung Taiwan 14 998 0.9× 902 0.8× 73 0.5× 114 0.9× 60 0.5× 19 1.2k
Glenn B. Knight United States 14 905 0.8× 720 0.7× 89 0.6× 114 0.9× 281 2.4× 18 1.4k
C. Bréchot France 15 861 0.8× 919 0.9× 96 0.6× 163 1.3× 220 1.8× 55 1.2k
Shogo Ohkoshi Japan 15 1.7k 1.5× 1.4k 1.3× 154 1.0× 148 1.2× 376 3.2× 45 2.2k
Patrick Soussan France 23 836 0.7× 1.0k 1.0× 175 1.2× 188 1.5× 381 3.2× 47 1.5k
Tomoteru Kamimura Japan 16 431 0.4× 409 0.4× 129 0.9× 88 0.7× 83 0.7× 54 747

Countries citing papers authored by Anna Suk‐Fong Lok

Since Specialization
Citations

This map shows the geographic impact of Anna Suk‐Fong Lok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Suk‐Fong Lok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Suk‐Fong Lok more than expected).

Fields of papers citing papers by Anna Suk‐Fong Lok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Suk‐Fong Lok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Suk‐Fong Lok. The network helps show where Anna Suk‐Fong Lok may publish in the future.

Co-authorship network of co-authors of Anna Suk‐Fong Lok

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Suk‐Fong Lok. A scholar is included among the top collaborators of Anna Suk‐Fong Lok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Suk‐Fong Lok. Anna Suk‐Fong Lok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cornberg, Markus, Anna Suk‐Fong Lok, Norah A. Terrault, & Fabien Zoulim. (2019). Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference. Hepatology. 71(3). 1070–1092. 77 indexed citations
2.
Lok, Anna Suk‐Fong. (2018). Hepatitis B Treatment: What We Know Now and What Remains to Be Researched. Hepatology Communications. 3(1). 8–19. 79 indexed citations
3.
Lok, Anna Suk‐Fong. (2015). Hepatitis B: 50 years after the discovery of Australia antigen. Journal of Viral Hepatitis. 23(1). 5–14. 25 indexed citations
4.
Lok, Anna Suk‐Fong. (2014). Progress in Hepatitis B: A 30-Year Journey Through Three Continents. Hepatology. 60(1). 4–11. 6 indexed citations
5.
Lok, Anna Suk‐Fong. (2012). HCV NS5A Inhibitors in Development. Clinics in Liver Disease. 17(1). 111–121. 29 indexed citations
6.
Lok, Anna Suk‐Fong. (2010). Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?. Journal of Gastroenterology and Hepatology. 26(2). 221–227. 38 indexed citations
7.
Jafri, Syed‐Mohammed & Anna Suk‐Fong Lok. (2010). Antiviral Therapy for Chronic Hepatitis B. Clinics in Liver Disease. 14(3). 425–438. 31 indexed citations
8.
Ito, Kiyoaki, Kyun‐Hwan Kim, Anna Suk‐Fong Lok, & Shuping Tong. (2009). Characterization of Genotype-Specific Carboxyl-Terminal Cleavage Sites of Hepatitis B Virus e Antigen Precursor and Identification of Furin as the Candidate Enzyme. Journal of Virology. 83(8). 3507–3517. 69 indexed citations
9.
Lok, Anna Suk‐Fong. (2007). Navigating the Maze of Hepatitis B Treatments. Gastroenterology. 132(4). 1586–1594. 44 indexed citations
10.
Lok, Anna Suk‐Fong, Marc G. Ghany, Zachary Goodman, et al.. (2005). Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort Potential conflict of interest: Nothing to report.. 1 indexed citations
11.
Conjeevaram, Hari S. & Anna Suk‐Fong Lok. (2003). Management of chronic hepatitis B. Journal of Hepatology. 38. 90–103. 208 indexed citations
12.
Chu, Chi‐Jen & Anna Suk‐Fong Lok. (2002). Clinical utility in quantifying serum HBV DNA levels using PCR assays. Journal of Hepatology. 36(4). 549–551. 36 indexed citations
13.
Lok, Anna Suk‐Fong. (2000). Hepatitis B infection: Pathogenesis and management. Journal of Hepatology. 32(1 Suppl). 89–97. 113 indexed citations
14.
15.
Lai, Ching‐Lung, et al.. (1988). Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer. 62(3). 479–483. 291 indexed citations
16.
Lai, Ching‐Lung, et al.. (1987). PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN. The Lancet. 330(8564). 877–880. 134 indexed citations
17.
Lok, Anna Suk‐Fong, et al.. (1987). HEPATITIS B VIRUS INFECTION IN CHINESE FAMILIES IN HONGKONG. American Journal of Epidemiology. 126(3). 492–499. 126 indexed citations
18.
Hui, Wai‐Mo, Matthew Ng, Ching‐Lung Lai, et al.. (1986). Chronic Antral Gastritis in Duodenal Ulcer. Gastroenterology. 91(5). 1095–1101. 25 indexed citations
19.
Hui, Wai‐Mo, et al.. (1986). Sulpiride improves functional dyspepsia: A double‐blind controlled study. Journal of Gastroenterology and Hepatology. 1(5). 391–399. 9 indexed citations
20.
Lok, Anna Suk‐Fong, et al.. (1986). Response to hepatitis B vaccine in family members of HBsAg carriers. Journal of Medical Virology. 19(1). 33–39. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideharu Harada Breakdown of academic impact, for papers by Jane Fang Breakdown of academic impact, for papers by Akito Nozaki Breakdown of academic impact, for papers by Byung‐Cheol Song Breakdown of academic impact, for papers by J L Sung Breakdown of academic impact, for papers by Glenn B. Knight Breakdown of academic impact, for papers by C. Bréchot Breakdown of academic impact, for papers by Shogo Ohkoshi Breakdown of academic impact, for papers by Patrick Soussan Breakdown of academic impact, for papers by Tomoteru Kamimura
Rankless by CCL
2026